# Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development

> **NIH NIH N01** · EMORY UNIVERSITY · 2022 · $106,523

## Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations  is also available.

## Key facts

- **NIH application ID:** 10673575
- **Project number:** 272201300018I-P00008-759301900132-1
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Mark Joseph Mulligan
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $106,523
- **Award type:** —
- **Project period:** 2019-07-12 → 2023-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10673575

## Citation

> US National Institutes of Health, RePORTER application 10673575, Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development (272201300018I-P00008-759301900132-1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10673575. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*